|
Maxwell Biotech Venture Fund Invests in Pivotal Clinical Trial of Oxagen's …
Laser Focus world Maxwell Biotech Venture Fund (MBVF), founded with the help of Russian government-backed RVC, announced today that its investment committee approved the terms and the amount of an investment in Eleventa, a Russian biotech company, which was … |
View full post on asthma – Google News